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Abstract: 
Screening of “drug-like” molecule from the molecular database produced through high throughput techniques and their large 
repositories requires robust classification. In our work, a set of heuristically chosen nine molecular descriptors including four 
from Lipinski’s rule, were used as classification parameter for screening “drug-like” molecules. The robustness of 
classification was compared with four fundamental descriptors of Lipinski. Back propagation neural network based classifier 
was applied on a database of 60000 molecules for classification of, “drug-like” and “non drug-like” molecules. Classification 
result using nine descriptors showed high classification accuracy of 96.1% in comparison to that using four Lipinski’s 
descriptors which yielded an accuracy of 82.48%. Also a significant decrease of false positives resulted while using nine 
descriptors causing a sharp 18% increase of specificity of classification. From this study it appeared that Lipinski’s 
descriptors which mainly deal with pharmacokinetic properties of molecules form the basis for identification of “drug-like” 
molecules that can be substantially improved by adding more descriptors representing pharmaco-dynamics properties of 
molecules. 
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Background: 
Discriminating “drug-like” molecules from non-drug like 
molecules is one of the prime focuses of current research in 
the field of computer aided drug design. Concept of drug 
likeness is important in both combinatorial chemistry and 
high throughput screening which deal with synthesis of 
libraries of molecules and their evaluation respectively [1]. 
Combinatorial chemistry has emerged as a new paradigm 
in the field of drug discovery as it provides a large library 
of compounds at a time. Moreover the number of 
commercially available compounds is also going on 
increasing. So the process of compound selection and 
prioritization is very crucial to reduce the time and 
computational cost of screening the libraries of compounds 
to get compounds feasible for synthesis and further testing 
[2]. In this scenario the concepts and methods to predict 
drug-likeness of enormous number of molecules available 
through miscellaneous sources in the libraries becomes 
important.  
 
Drug-likeness can be deduced as a delicate balance among 
molecular properties affecting pharmaco-dynamics and 
pharmacokinetics of molecules which ultimately affects 
their absorption, distribution, metabolism, and excretion in 
human body like a drug. Molecular properties include 
molecular weight, electronic distribution, hydrophobicity, 
hydrogen bond donors/acceptors, solubility, viscosity, 
excess volume and other related properties. For 
computational studies these molecular properties have to 
be logically and quantitatively represented as molecular 
descriptors in such a way that their complete chemical 
information remains preserved [3]. Selection of suitable 
molecular descriptors for correctly predicting the drug-
likeness of a molecule is of prime importance for the 
screening the drug-like molecules.  
 
Methods for drug-likeness prediction include from simple 
counting schemes like Lipinski’s “rule of five” to machine 
learning approaches like artificial neural network and 
support vector machines [4]. Lipinski’s “rule of five” is a 
heuristic approach for predicting drug-likeness stating that 
molecules having molecular weight >500, log P >5, 
hydrogen bond donors >5 and hydrogen bond acceptors 
>10 have poor absorption or permeation [5]. This rule 
describes only the molecular properties related with 
pharmacokinetics of molecules which refers to the 
absorption, distribution, metabolism and excretion 
(ADME) of bioactive compounds in a higher organism. 
There is no consideration for pharmaco-dynamics aspect of 
molecules which deal with drug action on the body or on 
microorganisms and other parasites within or on the body. 
Moreover there are many violations of this rule among 
existing drugs and vice versa, and therefore, qualifying the 
“rule of five” does not guarantee that a molecule is “drug-
like” [6].   
 
Other methods include ‘knowledge based method’ by 
Andrews et al., considering intrinsic binding energies and 
structural fragments i.e., functional groups. This method is 
based on intrinsic energies derived from 200 molecules [7]. 
Walter  et al., proposed ‘REOS (Rapid Elimination of 
Swill) approach’ as a hybrid of simple counting method 
and functional group filtering method. Functional group 
filters used in this method identify reactive, toxic and 
undesirable moieties [8]. Initial filtering is based on seven 
properties including molecular weight, logP, hydrogen 
bond donors, hydrogen bond acceptors, formal charge, 
number of rotatable bonds and number of heavy atoms. 
REOS also employs a set of more than 200 rules based on 
presence of functional groups known to be problematic. 
 
In addition, machine learning approaches are being used 
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Sadowski and Kubinyi designed a feed forward neural 
network with 92 input nodes, five hidden nodes and one 
output node to predict drug-likeness [9]. They 
characterized the molecules using a set of 92 atom types 
originally devised for the purpose of predicting logP by 
Ghose and Krippen [10]. Their neural network classified 
77% “drug-like” and 83% “non drug-like” molecules 
correctly. Two important aspects to be considered in 
machine learning based approaches are the choice of 
appropriate descriptors and the number of descriptors to be 
used at the time of creating the model. Representation of 
chemical structures by appropriate descriptors is the key to 
success in establishing useful relationships using machine 
learning approaches [11]. Evidently, larger the number of 
relevant descriptors more will be the efficiency for drug-
likeness classification using machine learning approach 
[12]. These facts suggest the requirement of improvement 
in classical approaches for predicting drug-likeness of 
molecules by adding more suitable descriptors as 
classifying parameters. In this context additional 
descriptors were deterministically selected in our work to 
account for pharmaco-dynamic properties of molecules. 
Use of these descriptors as input into back propagation 
network classifier appeared to be the possible cause of 
improvement in overall classification efficiency. Thus it is 
a tradeoff between requirement of additional descriptors 
and removal of redundant descriptors for better prediction 
of drug-likeness.  
 
Methodology: 
Dataset  
Data was downloaded from ZINC database [13]. Each 
molecule in ZINC database is represented by its three 
dimensional structure, SMILES representation and 
corresponding molecular descriptors. Descriptor values 
available in ZINC database are calculated using 
“Molinspiration MiTools” molecular processing toolkit 
and were used as such for our study [14]. For this study 
30000 “drug-like” and 30000 “nondrug-like” molecules 
were used as working database. Within this database 20000 
and 10000 molecules from both the groups constituted 
training and test set respectively. 
 
Selection of molecular descriptors 
Two different data sets were prepared depending upon the 
choice of descriptors. In first data set molecules were 
represented by a vector of nine descriptors representing 
Molecular weight (MW), logP (LP), apolar desolvation 
energy (ADE), polar desolvation energy (PDE), number of 
H bond donors (HBD), number of H bond acceptors 
(HBA), total polar surface area (TPSA), charge (Ch) and 
number of rotatable bonds (RB). Second data set 
comprised of same molecules represented by four 
descriptors: molecular weight, log P, number of H-bond 
donors, and number of H-bond acceptors. These four 
descriptors are considered in Lipinski’s “rule of five” and 
were used for the purpose of benchmarking. Descriptors 
considered in Lipinski’s rule are directly related to 
pharmacokinetic properties (Absorption-Distribution-
Metabolism-Excretion-Toxicity properties) of molecules. 
Other five descriptors selected i.e., apolar desolvation 
energy, polar desolvation energy, total polar surface area, 
charge and number of rotatable bonds are related to 
pharmacodynamic aspect of molecules. Thus the selected 
descriptors cover both the pharmacokinetic and pharmaco-
dynamics aspects of drug action. 
 
Preprocessing the data 
Data was normalized to scale it down to the range between 
0 and 1, using min max normalization method [15]. 
Normalized values can be represented by equation 1 in 
supplementary material.  
 
 
Figure 1: Measures of efficiency of classification. Bars named as ‘A’ represent values for nine descriptor data set and bars 
named as ‘B’ represent values for Lipinski’s descriptor data set.  
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Classification by back propagation Artificial Neural 
Network (ANN) 
The classification decision was obtained with the help of a 
feed-forward back propagation network where normalized 
descriptor-vectors were used as input. Several neural 
network architectures were tried for training using data 
containing nine descriptors. The most efficient one was 
chosen as final network architecture. It consists of two 
hidden layers apart from input and output layers. While the 
input layer comprises of nine nodes, first and second 
hidden layers consist of seven and five nodes respectively. 
Output layer contains one node to represent two classes of 
our interest. Transfer function used in both hidden layers 
was tan sigmoid and that used in output layer was linear. 
Weights and biases of the neural network were optimized 
during training using gradient descent method. Mean 
square error was used as performance function. Similar 
neural network architecture with only exception of four 
input nodes was used for data set containing only 
Lipinski’s descriptors. For training set target output was 
kept as 1 for “drug-like” molecules and -1 for “non drug-
like” molecules. For testing the trained neural network an 
error margin was taken as 0.10. Molecules giving output 
>0.90 were considered as “drug-like” and those giving 
output <-0.90 were classified as “non drug-like” 
molecules.  
 
Assessment of efficiency of classification  
As the classification of small molecules into “drug-like” 
and “non drug-like” classes is a binary classification; 
sensitivity, specificity and accuracy are appropriate 
measures for assessing efficiency of classification [17]. 
While sensitivity is the proportion of true positives 
classified as positives, specificity can be defined as the 
proportion of true negatives classified as negatives. 
Accuracy is the proportion of true positives and true 
negatives classified as positives and negatives respectively. 
These measures were calculated for neural networks 
trained with nine descriptor data set and four descriptors 
data set separately.  
 
Discussion: 
The study was aimed at comparing the efficiency of 
different descriptor sets in classifying small molecules into 
“drug-like” and “nondrug-like” classes, the result of which 
is summarized in table 2. There was consistent 
improvement in all the considered measures of 
performance of the network trained with all the nine 
descriptors in comparison to the network trained with 
Lipinski’s four descriptors only. The improvements found 
in sensitivity, specificity and accuracy were 9%, 18.29% 
and 13.64% respectively, as visualized in histogram chart 
in figure 1. The most significant improvement was found 
in specificity as there was a decrease of ~3.5 times in the 
number of false positives detected using nine descriptors 
data set in comparison to Lipinski’s descriptors data set. 
The consistent improvement in efficiency measures of 
classification as shown in figure 1 indicates that there is 
further scope of improvement in building a protocol based 
on addition of more descriptors for distinguishing between 
“drug-like” and “non drug-like” molecules over that of 
Lipinski’s “rule of five”. Our study also supports the 
studies done by Oprea (2000) and Frimurer (2000) which 
concluded that Lipinski’s “rule of five” has limitations in 
distinguishing between “drug-like” and “non drug-like” 
molecules [1, 18]. The basis behind these findings is that 
the distribution of descriptors considered in Lipinski’s 
“rule of five”, does not differ significantly between the 
“drug-like” and “non drug-like” molecules most possibly 
because of the consideration of their pharmacokinetic 
properties only. Moreover, the contribution of a particular 
input descriptor in the final decision making stage can be 
evaluated by optimizing the weights of artificial neural 
network classifier linking inputs with outputs where very 
small value of weight will be assigned to the least 
contributing input [19]. It is well documented in literature 
that normalization of input data vector improves the 
efficiency of neural network classifier [15]. Moreover we 
considered the maximum error margin of 0.10. This makes 
our classifier very stringent in comparison to traditional 
neural network classifier where the molecules giving 
output <0 and >0, would have been classified into “non 
drug-like” and “drug-like” classes respectively. Thus our 
classifier had very stringent criteria for classification of 
molecules into their respective classes relaxing which a 
further improvement in efficiency can be obtained at the 
cost of degrading the reliability of decision. As discussed 
in the methodology section all the parameters related to 
neural network architecture were kept same for both the 
data sets with only exception in input layer. This reduced 
any chance of difference in efficiency of classifier due to 
any factor related to the classifier other then the descriptor 
set used in training and test sets. 
 
Conclusion: 
Our approach dealt with the problem of drug-likeness 
prediction in a different perspective. It showed that rule 
based approach for drug-likeness prediction has scope for 
improvement. Machine learning approach shows good 
efficiency for drug-likeness prediction. Appropriate choice 
and number of descriptors is of prime importance for 
application of machine learning approaches for drug-
likeness prediction. Another important aspect of this study 
was consideration of the reliability of the classifier that 
was achieved by keeping the permissible error margin of 
output as 0.1. Such stringent considerations made the 
classifier more reliable which most possibly helped to 
eliminate false positives which is crucial for screening 
“drug-like” molecules.   
 
Acknowledgement: 
We hereby acknowledge the helpful discussion we had 
with Manish Kumar, Indian Institute of Information 
Technology (IIIT), Allahabad, India. We are also grateful 
to Ministry of Human Resource and Development 
(MHRD) and Department of Science and Technology 
(DST) for their joint financial support to Bioinformatics 
Division of IIIT to continue this work. 
 
References: 
[1]  T. I. Oprea, J Comput Aided Mol Des. (2000) 
14(3):251 [PMID: 10756480] 
[2]  H. Kubinyi, Perspect. Drug Discov. Design (1998) 
9(11):225 
[3]  http://www.moleculardescriptors.eu/ Bioinformation by Biomedical Informatics Publishing Group                       open access 
 www.bioinformation.net                                                                     Hypothesis 
ISSN 0973-2063 (online) 0973-8894 (print)    
Bioinformation 3(9): 384-388 (2009)                                                  Bioinformation, an open access forum  
                                                                                                                                              © 2009 Biomedical Informatics Publishing Group 
 
387
[4]  W. Patrick Walters & Mark A. Murcko, Adv. Drug 
Deliv. Rev. (2002) 54(3):255 [PMID: 11922947] 
[5]  C. A. Lipinski, J Pharmacol. Toxicol. Methods. 
(2000) 44(1):235 [PMID: 11274893] 
[6]  R. U. Kadam & N. Roy, Indian J. Pharm. Sci. 
(2007) 69(5):609 
[7]  P. R.  Andrews et al., J. Med. Chem. (1984) 
27(12):1648 [PMID: 6094812] 
[8]  W. Patrick Walters & Mark Namchuk , Nat. Rev. 
Drug Discov. (2003) 2(4):259 [PMID: 12669025] 
[9]  A. K. Ghose & G. M. Crippen, J. Comput. Chem. 
(1986) 7(4):565 
[10]  J. Sadowski & H. Kubinyi, J. Med. Chem. (1998) 
41(18):3325 [PMID: 9719584] 
[11]  J. Gasteiger et al., J. Phys. Org. Chem. (2003) 
16(4):232 
[12]  Q. Li et al., J Chem Inf Model. (2007) 47(5):1776 
[PMID: 17718552] 
[13]  J.  J. Irwin & B. K. Shoichet, J. Chem. Inf. Model. 
(2005) 45(1):177 [PMID: 15667143] 
[14]  http://www.molinspiration.com/ 
[15]  A. Givehchi & G. Schneider, J. Mol. Model. (2004) 
10(3):204 [PMID: 15067522] 
[16]  L. A. Shalabi et al., Journal of Computer Science 
(2006) 2(9):735  
[17]  P. Baldi et al., Bioinformatics (2000) 16(5):412 
[PMID: 10871264] 
[18]  T. M. Frimurer et al., J. Chem. Inf. Comput. Sci. 
(2000) 40(6):1315 [PMID: 11128089] 
[19]  http://www.makhfi.com/why_ann.htm 
Edited by P. Kangueane 
Citation: Mishra et al, Bioinformation 3(9): 384-388 (2009)  
License statement: This is an open-access article, which permits unrestricted use, distribution, and reproduction in  
                                                     any medium, for non-commercial purposes, provided the original author and source are 
credited. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Bioinformation by Biomedical Informatics Publishing Group                       open access 
 www.bioinformation.net                                                                     Hypothesis 
ISSN 0973-2063 (online) 0973-8894 (print)    
Bioinformation 3(9): 384-388 (2009)                                                  Bioinformation, an open access forum  
                                                                                                                                              © 2009 Biomedical Informatics Publishing Group 
 
388
Supplementary material 
Equation 1 
v'=(v − minA)( new_maxA − new_minA) ⁄ (maxA − minA) + new_minA 
 
where v' is the normalized descriptor value, v is the original descriptor value, maxA and minA represent original maxima and 
minima of concerned descriptor. New_maxA and new_minA represent maxima and minima defined for normalized descriptor 
value [16]. Table 1 shows the values of descriptors before and after normalization. 
 
 MW  LP  ADE  PDE  HBD  HBA  TPSA  Ch  RB 
249.354 2.58  -1.44 -40.22 0  2  41  1  3 
162.192 1.06  -6.25  -5.6  0  2  47  0  3 
Original 
Descriptor 
Vectors 
152.149 0.37  -1.17 -46.53 0  2  57  -1  3 
0.249 0.483  0.382  0.911 0 0.067 0.228  0.5  0.1 
0.162 0.419  0.114  0.988 0 0.067 0.261 0.333  0.1 
 Normalized 
Descriptor 
vectors 
0.152 0.390  0.397  0.897 0 0.067 0.317 0.167  0.1 
Table 1: Sample representation of original and normalized descriptor vectors is given. 
 Test  data  for 
molecules 
TP TN FP FN  Sensitivity Specificity Accuracy 
Nine descriptor data set  20000  9945  9280  720  55  99.45%  92.80%  96.12% 
Lipinski’s rule descriptor data 
set 
20000  9045 7451 2549 955  90.45%  74.51%  82.48% 
Table 2: Detailed results of both datasets are given. TP= number of true positives, TN= number of true negatives, FP= 
number of false positives, FN=number of false negatives 
 